
Drug Benefit Trends
- Drug Benefit Trends Vol 21 No 3
- Volume 21
- Issue 3
Digestive Diseases Cost $141.8 Billion Annually
Digestive diseases are costly to manage, with annual costs totaling $141.8 billion in 2004 (Figure 1), according to an NIH report. Direct costs associated with digestive diseases jumped from $85 billion in 1998 to nearly $98 billion in 2004. Prescription drug costs alone were $12.3 billion. Indirect costs for digestive diseases more than doubled, from $20 billion in 1998 to $44 billion in 2004, of which $32.8 billion was associated with lost productivity caused by increased mortality.
Digestive diseases are costly to manage, with annual costs totaling $141.8 billion in 2004 (
Digestive cancers were the most costly digestive diseases in total annual costs, accounting for $24.1 billion (
Approximately 70 million US adults are affected by digestive diseases. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) estimates that 50 million persons are lactose intolerant (
Articles in this issue
about 17 years ago
Genetic Polymorphism and Major Depression: New Theoriesabout 17 years ago
Insulin: A Possible Treatment for AD?about 17 years ago
Financial Incentives Spur Smoking Cessationabout 17 years ago
Managing Drug Interactions That Can Reduce Levothyroxine Efficacyabout 17 years ago
Optimizing the Use of Cost-Sharing Strategiesabout 17 years ago
Prevention as a Replacement for Breakdown Medicineabout 17 years ago
Using Biomarkers to Guide Therapy, Coverage Decisionsabout 17 years ago
Clinicians Override Most Rx Safety Alertsabout 17 years ago
Metabolic Agents Lead Drug Expenditures
















































































































































